What is the recommended treatment for Type 1 Von Willebrand Disease?

• A. Factor VIII replacement
• B. Heparin infusion
• C. Desmopressin
• D. Vitamin K supplementation

Answer: (C)

The recommended treatment for Type 1 Von Willebrand Disease is desmopressin. This synthetic medication works by stimulating the release of von Willebrand factor (vWF) from the endothelial cells, thereby increasing the levels of both vWF and Factor VIII in circulation. This helps to improve clotting in patients who have deficiencies or dysfunction in these proteins, which are crucial for proper hemostasis.

Desmopressin is typically the first-line treatment for mild to moderate cases of Von Willebrand Disease, as it can effectively elevate vWF levels and improve bleeding symptoms. Its use is particularly beneficial because it can be administered easily and has a relatively favorable safety profile.

Factor VIII replacement is not appropriate as a primary treatment for Type 1 Von Willebrand Disease, since the underlying issue is the deficiency in vWF rather than a primary deficiency in Factor VIII alone. Heparin infusion is primarily used as an anticoagulant and is not suitable for treating bleeding disorders related to Von Willebrand Disease. Vitamin K supplementation is relevant for conditions related to deficiencies in vitamin K-dependent clotting factors, but it does not address the specific issues present in Von Willebrand Disease, making it ineffective in this context.